Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARMUSTINE vs CASPOFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARMUSTINE vs CASPOFUNGIN: Safety Overview

Metric CARMUSTINE CASPOFUNGIN
Total FAERS Reports 3,376 3,814
Deaths Reported 781 1,419
Death Rate 23.1% 37.2%
Hospitalizations 873 1,638
Average Patient Age 52.0 yrs 47.5 yrs
% Female Patients 33.8% 42.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 30, 2016
Manufacturer Amneal Pharmaceuticals LLC Sandoz Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued